ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"
By
ecancer
FEATURING
Jennifer Knox
By
ecancer
FEATURING
Jennifer Knox
Comments 0
Login to view comments.
Click here to Login
